Laser resurfacing safety and complications — the management of post-inflammatory hyperpigmentation, infection, scarring, hypopigmentation, and prolonged erythema representing the safety challenges that shape treatment protocols, patient selection, and regulatory oversight — are critical market quality dimensions, with the Laser Resurfacing Market reflecting safety as a fundamental market quality determinant.

Post-inflammatory hyperpigmentation (PIH) risk — the darkening of treated skin from melanocyte stimulation during healing, occurring most frequently in Fitzpatrick skin types III-VI, representing the most common laser resurfacing complication — creates the clinical challenge that has driven picosecond adoption and careful patient selection protocols. PIH prevention protocols including pre-treatment hydroquinone, sunscreen compliance, and careful laser parameter selection creating the clinical management approach that distinguishes skilled from unskilled practitioners.

Herpes simplex virus prophylaxis — the mandatory antiviral prophylaxis (acyclovir, valacyclovir) for all laser resurfacing patients with history of oral herpes simplex preventing the devastating complication of HSV viral activation in post-laser wound — creates the pharmaceutical adjunct essential to safe ablative laser practice. Viral activation complication causing severe scarring and bacterial superinfection representing the preventable complication that appropriate protocol eliminates.

FDA oversight of aesthetic laser devices — the 510(k) clearance process for laser devices, the FDA's adverse event reporting database for laser complications, and the evolving discussion about appropriate training standards for laser operators — creates the regulatory framework that influences market practices. Some states implementing laser operator training requirements while others maintaining minimal oversight creating the regulatory patchwork.

Do you think more stringent US regulation of who can operate aesthetic laser devices (requiring physician or advanced practitioner supervision) would improve safety outcomes or primarily restrict market access unnecessarily?

FAQ

What are the main complications of laser resurfacing? Most common: post-inflammatory hyperpigmentation (PIH) — particularly darker skin types; prolonged erythema; acne flares; milia (small cysts); infection (bacterial, viral HSV, fungal); less common but serious: scarring (particularly with overlap or aggressive settings), hypopigmentation (permanent, especially full ablative), ectropion (eyelid complication); most complications preventable with proper patient selection, technique, and post-treatment care.

Who should not receive laser resurfacing? Contraindications: active herpes simplex without antiviral prophylaxis; active acne vulgaris (increased infection risk); recent isotretinoin use (within six to twelve months — impaired wound healing); unrealistic expectations; active skin infection; uncontrolled diabetes; known keloid tendency (relative); recent radiation therapy; immunosuppression; Fitzpatrick V-VI skin without experienced high-risk protocol management.

#LaserResurfacing #LaserSafety #PIHlaser #LaserComplications #HerpesProphylaxis #AestheticSafety